Cargando…
Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
BACKGROUND: Aberrant DNA methylation at imprinted loci is an important molecular mechanism contributing to several developmental and pathological disorders including cancer. However, knowledge about imprinting defects due to DNA methylation changes is relatively limited in hepatocellular carcinoma (...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606497/ https://www.ncbi.nlm.nih.gov/pubmed/26473022 http://dx.doi.org/10.1186/s13148-015-0145-6 |
_version_ | 1782395362390048768 |
---|---|
author | Anwar, Sumadi Lukman Krech, Till Hasemeier, Britta Schipper, Elisa Schweitzer, Nora Vogel, Arndt Kreipe, Hans Lehmann, Ulrich |
author_facet | Anwar, Sumadi Lukman Krech, Till Hasemeier, Britta Schipper, Elisa Schweitzer, Nora Vogel, Arndt Kreipe, Hans Lehmann, Ulrich |
author_sort | Anwar, Sumadi Lukman |
collection | PubMed |
description | BACKGROUND: Aberrant DNA methylation at imprinted loci is an important molecular mechanism contributing to several developmental and pathological disorders including cancer. However, knowledge about imprinting defects due to DNA methylation changes is relatively limited in hepatocellular carcinoma (HCC), the third leading cause of cancer death worldwide. Therefore, comprehensive quantitative DNA methylation analysis at imprinted loci showing ~50 % methylation in healthy liver tissues was performed in primary HCC specimens and the peritumoural liver tissues. RESULTS: We found frequent and extensive DNA methylation aberrations at many imprinted loci in HCC. Unsupervised cluster analysis of DNA methylation patterns at imprinted loci revealed subgroups of HCCs with moderate and severe loss of methylation. Hypomethylation at imprinted loci correlated significantly with poor overall survival (log-rank test, p = 0.02). Demethylation at imprinted loci was accompanied by loss of methylation at LINE-1, a commonly used marker for global DNA methylation levels (p < 0.001). In addition, we found that loss of methylation at imprinted loci correlated with the presence of a CTNNB1 mutation (Fisher’s exact test p = 0.03). Re-analysis of publically available genome-wide methylation data sets confirmed our findings. The analysis of benign liver tumours (hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH)), the corresponding adjacent liver tissues, and healthy liver tissues showed that aberrant DNA methylation at imprinted loci is specific for HCC. CONCLUSIONS: Our analyses demonstrate frequent and widespread DNA methylation aberrations at imprinted loci in human HCC and identified a hypomethylated subgroup of patients with shorter overall survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0145-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4606497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46064972015-10-16 Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival Anwar, Sumadi Lukman Krech, Till Hasemeier, Britta Schipper, Elisa Schweitzer, Nora Vogel, Arndt Kreipe, Hans Lehmann, Ulrich Clin Epigenetics Research BACKGROUND: Aberrant DNA methylation at imprinted loci is an important molecular mechanism contributing to several developmental and pathological disorders including cancer. However, knowledge about imprinting defects due to DNA methylation changes is relatively limited in hepatocellular carcinoma (HCC), the third leading cause of cancer death worldwide. Therefore, comprehensive quantitative DNA methylation analysis at imprinted loci showing ~50 % methylation in healthy liver tissues was performed in primary HCC specimens and the peritumoural liver tissues. RESULTS: We found frequent and extensive DNA methylation aberrations at many imprinted loci in HCC. Unsupervised cluster analysis of DNA methylation patterns at imprinted loci revealed subgroups of HCCs with moderate and severe loss of methylation. Hypomethylation at imprinted loci correlated significantly with poor overall survival (log-rank test, p = 0.02). Demethylation at imprinted loci was accompanied by loss of methylation at LINE-1, a commonly used marker for global DNA methylation levels (p < 0.001). In addition, we found that loss of methylation at imprinted loci correlated with the presence of a CTNNB1 mutation (Fisher’s exact test p = 0.03). Re-analysis of publically available genome-wide methylation data sets confirmed our findings. The analysis of benign liver tumours (hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH)), the corresponding adjacent liver tissues, and healthy liver tissues showed that aberrant DNA methylation at imprinted loci is specific for HCC. CONCLUSIONS: Our analyses demonstrate frequent and widespread DNA methylation aberrations at imprinted loci in human HCC and identified a hypomethylated subgroup of patients with shorter overall survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0145-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-15 /pmc/articles/PMC4606497/ /pubmed/26473022 http://dx.doi.org/10.1186/s13148-015-0145-6 Text en © Anwar et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Anwar, Sumadi Lukman Krech, Till Hasemeier, Britta Schipper, Elisa Schweitzer, Nora Vogel, Arndt Kreipe, Hans Lehmann, Ulrich Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival |
title | Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival |
title_full | Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival |
title_fullStr | Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival |
title_full_unstemmed | Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival |
title_short | Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival |
title_sort | loss of dna methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606497/ https://www.ncbi.nlm.nih.gov/pubmed/26473022 http://dx.doi.org/10.1186/s13148-015-0145-6 |
work_keys_str_mv | AT anwarsumadilukman lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival AT krechtill lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival AT hasemeierbritta lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival AT schipperelisa lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival AT schweitzernora lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival AT vogelarndt lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival AT kreipehans lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival AT lehmannulrich lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival |